UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006721 |
|---|---|
| Receipt number | R000007944 |
| Scientific Title | Phase II study of Pemetrexed plus Bevacizumab (YCRG04) in exacerbation cases of Non-squamous Non-small cell lung cancer, previously treated with bevacizumab plus platinum-based chemotherapy. |
| Date of disclosure of the study information | 2011/11/15 |
| Last modified on | 2017/01/30 12:51:24 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/11/14 17:19:55 | ||
| 2 | Update | 2012/08/29 14:28:58 | Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2013/04/02 15:44:30 | Email |
|
| 4 | Update | 2013/05/27 11:25:04 | Institutions |
|
| 5 | Update | 2013/11/25 10:10:55 | TEL |
|
| 6 | Update | 2014/11/17 09:59:00 | Last follow-up date |
|
| 7 | Update | 2014/11/17 10:01:51 | Name of person sending information Name of person sending information |
|
| 8 | Update | 2016/11/17 15:45:56 | Recruitment status |
|
| 9 | Update | 2017/01/30 12:51:24 | Recruitment status |
